Correction: Brusatol ameliorates psoriatic dyslipidemia by targeting IL-1β to restore AMPK-mediated lipid homeostasis

Yuankuan Jiang, Shumeng Zhang, Hewen Guan, Kejia lv, Jinchao Yu, Siyi Li, Renchuan Jia, Xiujie Zhang, Shurong Ma, Jialin Qu, Jingrong Lin · 2026

Read Correction: Brusatol ameliorates psoriatic dyslipidemia by targeting IL-1β to restore AMPK-mediated lipid homeostasis by Yuankuan Jiang, Shumeng Zhang, Hewen Guan, Kejia lv, Jinchao Yu, Siyi Li, Renchuan Jia, Xiujie Zhang, Shurong Ma, Jialin Qu, Jingrong Lin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13523190.txt.

Description

ells treated with brusatol (40 nM and 80 nM) in Fig. 5A were inadvertently duplicated. Brusatol suppresses lipid synthesis and accumulation in vitro and in vivo. A Representative Oil Red O-stained HepG2 cells induced with oleic acid (OA, 100 μM) and treated with Brusatol (40, 80, 160 nM) for 24 h.

Catalog record

CREATORYuankuan Jiang, Shumeng Zhang, Hewen Guan, Kejia lv, Jinchao Yu, Siyi Li, Renchuan Jia, Xiujie Zhang, Shurong Ma, Jialin Qu, Jingrong Lin
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13523190

Browse the full library · About the Tower of Babel